Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Celgene Revenue 2006-2019 | CELG

Celgene annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Celgene revenue for the quarter ending March 31, 2019 was $4.025B, a 13.76% increase year-over-year.
  • Celgene revenue for the twelve months ending March 31, 2019 was $15.768B, a 16.12% increase year-over-year.
  • Celgene annual revenue for 2018 was $15.281B, a 17.52% increase from 2017.
  • Celgene annual revenue for 2017 was $13.003B, a 15.8% increase from 2016.
  • Celgene annual revenue for 2016 was $11.229B, a 21.32% increase from 2015.
Celgene Annual Revenue
(Millions of US $)
2018 $15,281
2017 $13,003
2016 $11,229
2015 $9,256
2014 $7,670
2013 $6,494
2012 $5,507
2011 $4,842
2010 $3,626
2009 $2,690
2008 $2,255
2007 $1,406
2006 $899
2005 $537
Celgene Quarterly Revenue
(Millions of US $)
Q1 2019 $4,025
Q4 2018 $4,037
Q3 2018 $3,892
Q2 2018 $3,814
Q1 2018 $3,538
Q4 2017 $3,483
Q3 2017 $3,287
Q2 2017 $3,271
Q1 2017 $2,962
Q4 2016 $2,980
Q3 2016 $2,983
Q2 2016 $2,754
Q1 2016 $2,512
Q4 2015 $2,563
Q3 2015 $2,334
Q2 2015 $2,278
Q1 2015 $2,081
Q4 2014 $2,086
Q3 2014 $1,982
Q2 2014 $1,873
Q1 2014 $1,730
Q4 2013 $1,756
Q3 2013 $1,674
Q2 2013 $1,599
Q1 2013 $1,465
Q4 2012 $1,447
Q3 2012 $1,419
Q2 2012 $1,367
Q1 2012 $1,273
Q4 2011 $1,284
Q3 2011 $1,250
Q2 2011 $1,183
Q1 2011 $1,125
Q4 2010 $1,072
Q3 2010 $910
Q2 2010 $853
Q1 2010 $791
Q4 2009 $761
Q3 2009 $695
Q2 2009 $629
Q1 2009 $605
Q4 2008 $628
Q3 2008 $592
Q2 2008 $571
Q1 2008 $463
Q4 2007 $415
Q3 2007 $350
Q2 2007 $348
Q1 2007 $293
Q4 2006 $275
Q3 2006 $245
Q2 2006 $197
Q1 2006 $182
Q4 2005 $149
Q3 2005 $130
Q2 2005 $146
Q1 2005 $112
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $66.971B $15.281B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.610B 11.72
Gilead Sciences (GILD) United States $83.251B 10.11
Illumina (ILMN) United States $45.067B 52.23
Biogen (BIIB) United States $44.710B 8.49
Vertex Pharmaceuticals (VRTX) United States $42.742B 51.67
Regeneron Pharmaceuticals (REGN) United States $33.422B 15.71
Alexion Pharmaceuticals (ALXN) United States $28.794B 16.30
Incyte (INCY) United States $16.295B 66.08
BioMarin Pharmaceutical (BMRN) United States $15.608B 0.00
Exact Sciences (EXAS) United States $12.316B 0.00
Seattle Genetics (SGEN) United States $10.323B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
Sarepta Therapeutics (SRPT) United States $8.838B 0.00
QIAGEN (QGEN) Netherlands $8.400B 27.59
BeiGene (BGNE) Cayman Islands $7.980B 0.00
Moderna (MRNA) United States $7.607B 0.00
Bio-Techne Corp (TECH) United States $7.449B 50.82
Alnylam Pharmaceuticals (ALNY) United States $7.252B 0.00
Bluebird Bio (BLUE) United States $6.881B 0.00
Guardant Health (GH) United States $6.747B 0.00
Galapagos (GLPG) Belgium $5.856B 0.00
Exelixis (EXEL) United States $5.833B 14.87
Amarin (AMRN) Ireland $5.464B 0.00
Ascendis Pharma (ASND) Denmark $5.132B 0.00
Array BioPharma (ARRY) United States $4.918B 0.00
Spark Therapeutics (ONCE) United States $4.168B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.054B 0.00
Alkermes (ALKS) Ireland $3.990B 0.00
Blueprint Medicines (BPMC) United States $3.772B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.740B 0.00
China Biologic Products (CBPO) China $3.700B 23.50
Ultragenyx Pharmaceutical (RARE) United States $3.613B 0.00
Allogene Therapeutics (ALLO) United States $3.471B 0.00
Global Blood Therapeutics (GBT) United States $3.269B 0.00
Repligen (RGEN) United States $3.198B 79.66
MorphoSys AG Unsponsored ADR (MOR) Germany $3.126B 0.00
Amicus Therapeutics (FOLD) United States $2.890B 0.00
Immunomedics (IMMU) United States $2.860B 0.00
Arena Pharmaceuticals (ARNA) United States $2.774B 5.64
Reata Pharmaceuticals (RETA) United States $2.756B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.743B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.629B 0.00
Medicines (MDCO) United States $2.374B 0.00
Emergent Biosolutions (EBS) United States $2.325B 20.20
Halozyme Therapeutics (HALO) United States $2.298B 0.00
Mirati Therapeutics (MRTX) United States $2.289B 0.00
Ligand Pharmaceuticals (LGND) United States $2.259B 18.71
Insmed (INSM) United States $2.252B 0.00
Acceleron Pharma (XLRN) United States $2.219B 0.00
UniQure (QURE) Netherlands $2.212B 0.00
NeoGenomics (NEO) United States $2.203B 144.44
MyoKardia (MYOK) United States $2.189B 0.00
Genomic Health (GHDX) United States $2.093B 44.45
Denali Therapeutics (DNLI) United States $2.061B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.046B 0.00
Akcea Therapeutics (AKCA) United States $2.016B 0.00
AnaptysBio (ANAB) United States $1.960B 0.00
Myriad Genetics (MYGN) United States $1.948B 19.38
Nabriva Therapeutics AG (NBRV) Ireland $1.917B 0.00
Allakos (ALLK) United States $1.796B 0.00
Audentes Therapeutics (BOLD) United States $1.693B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.680B 0.00
REGENXBIO (RGNX) United States $1.674B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.651B 0.00
Alector (ALEC) United States $1.503B 0.00
Innoviva (INVA) United States $1.490B 4.12
Cambrex (CBM) United States $1.474B 18.63
Lion Biotechnologies (IOVA) United States $1.387B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.365B 0.00
Gossamer Bio (GOSS) United States $1.350B 0.00
Aimmune Therapeutics (AIMT) United States $1.305B 0.00
Rubius Therapeutics (RUBY) United States $1.262B 0.00
Fate Therapeutics (FATE) United States $1.197B 0.00
Apellis Pharmaceuticals (APLS) United States $1.197B 0.00
Coherus BioSciences (CHRS) United States $1.192B 0.00
Sangamo Therapeutics (SGMO) United States $1.185B 0.00
Atara Biotherapeutics (ATRA) United States $1.151B 0.00
Editas Medicine (EDIT) United States $1.114B 0.00
InflaRx (IFRX) Germany $1.080B 0.00
Codexis (CDXS) United States $1.056B 0.00
Epizyme (EPZM) United States $1.041B 0.00
RA PHARMCTL INC (RARX) United States $1.020B 0.00
Clovis Oncology (CLVS) United States $0.995B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.959B 0.00
Myovant Sciences (MYOV) United Kingdom $0.957B 0.00
Eidos Therapeutics (EIDX) United States $0.956B 0.00
Athenex (ATNX) United States $0.940B 0.00
WAVE Life Sciences (WVE) Singapore $0.927B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.914B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.907B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.896B 0.00
G1 THERAPEUTICS (GTHX) United States $0.891B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.874B 0.00
NGM Biopharmaceuticals (NGM) United States $0.868B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.866B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.847B 39.97
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.821B 0.00
ANI Pharmaceuticals (ANIP) United States $0.819B 14.77
Cellectis (CLLS) France $0.793B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.779B 0.00
Retrophin (RTRX) United States $0.769B 0.00
Axsome Therapeutics (AXSM) United States $0.766B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.759B 0.00
Vericel (VCEL) United States $0.748B 0.00
Principia Biopharma (PRNB) United States $0.744B 0.00
Cara Therapeutics (CARA) United States $0.744B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.742B 0.00
MeiraGTx Holdings (MGTX) United States $0.741B 0.00
Intellia Therapeutics (NTLA) United States $0.726B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.716B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.687B 0.00
Twist Bioscience (TWST) United States $0.684B 0.00
Intra-Cellular Therapies (ITCI) United States $0.681B 0.00
Arvinas (ARVN) United States $0.672B 0.00
Precision BioSciences (DTIL) United States $0.641B 0.00
Puma Biotechnology (PBYI) United States $0.641B 0.00
Stemline Therapeutics (STML) United States $0.635B 0.00
Zealand Pharma (ZEAL) Denmark $0.628B 6.99
Heska (HSKA) United States $0.620B 63.51
Cytokineticsorporated (CYTK) United States $0.616B 0.00
Kura Oncology (KURA) United States $0.615B 0.00
Viking Therapeutics (VKTX) United States $0.613B 0.00
ObsEva SA (OBSV) Switzerland $0.604B 0.00
Zymeworks (ZYME) Canada $0.582B 0.00
MediciNova (MNOV) United States $0.558B 0.00
Revance Therapeutics (RVNC) United States $0.558B 0.00
DBV Technologies (DBVT) France $0.553B 0.00
Scholar Rock Holding (SRRK) United States $0.549B 0.00
Magenta Therapeutics (MGTA) United States $0.545B 0.00
Anika Therapeutics (ANIK) United States $0.543B 18.55
Acorda Therapeutics (ACOR) United States $0.543B 9.56
UROGEN PHARMA (URGN) United States $0.540B 0.00
Synthorx (THOR) United States $0.518B 0.00
Krystal Biotech (KRYS) United States $0.506B 0.00
Mesoblast (MESO) Australia $0.495B 0.00
CytomX Therapeutics (CTMX) United States $0.492B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.478B 0.00
Sorrento Therapeutics (SRNE) United States $0.478B 0.00
Albireo Pharma (ALBO) United States $0.456B 0.00
Replimune (REPL) United States $0.453B 0.00
AVROBIO (AVRO) United States $0.444B 0.00
Kaleido Biosciences (KLDO) $0.438B 0.00
Arcus Biosciences (RCUS) United States $0.433B 0.00
Dynavax Technologies (DVAX) United States $0.431B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.431B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.423B 0.00
BioDelivery Sciences (BDSI) United States $0.414B 0.00
Adverum Biotechnologies (ADVM) United States $0.409B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.405B 0.00
Senesco Technologies (ELOX) United States $0.399B 0.00
UNITY Biotechnology (UBX) $0.399B 0.00
Agenus (AGEN) United States $0.399B 0.00
Gritstone Oncology (GRTS) United States $0.394B 0.00
Cyclerion Therapeutics (CYCN) United States $0.392B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.391B 0.00
Kezar Life Sciences (KZR) United States $0.389B 0.00
Prothena (PRTA) Ireland $0.388B 0.00
PDL BioPharma (PDLI) United States $0.387B 9.17
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Abeona Therapeutics (ABEO) United States $0.358B 0.00
Kindred Biosciences (KIN) United States $0.351B 0.00
AC Immune SA (ACIU) Switzerland $0.349B 22.43
HOOKIPA PHARMA (HOOK) United States $0.346B 0.00
Inovio Pharmaceuticals (INO) United States $0.342B 0.00
XBiotech (XBIT) United States $0.339B 0.00
Geron (GERN) United States $0.334B 0.00
Five Prime Therapeutics (FPRX) United States $0.331B 0.00
BeyondSpring (BYSI) United States $0.330B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.328B 0.00
LogicBio Therapeutics (LOGC) United States $0.327B 0.00
Merus (MRUS) Netherlands $0.315B 0.00
Palatin Technologies (PTN) United States $0.315B 0.00
Cellular Biomedicine (CBMG) United States $0.299B 0.00
Kadmon Holdings (KDMN) United States $0.297B 0.00
Constellation Pharmaceuticals (CNST) United States $0.289B 0.00
Mersana Therapeutics (MRSN) United States $0.286B 0.00
PHASEBIO PHARMA (PHAS) United States $0.286B 0.00
Kodiak Sciences (KOD) United States $0.285B 0.00
Athersys (ATHX) United States $0.282B 0.00
ResTORbio (TORC) United States $0.280B 0.00
ChromaDex (CDXC) United States $0.263B 0.00
Aduro Biotech (ADRO) United States $0.263B 0.00
Evelo Biosciences (EVLO) United States $0.253B 0.00
Protagonist Therapeutics (PTGX) United States $0.253B 0.00
Arsanis (XFOR) United States $0.249B 0.00
MannKind (MNKD) United States $0.248B 0.00
Cel-Sci (CVM) United States $0.246B 0.00
Kamada (KMDA) Israel $0.235B 9.11
Cerecor (CERC) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.235B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
Pfenex (PFNX) United States $0.228B 0.00
Enochian BioSciences (ENOB) United States $0.226B 0.00
OvaScience (MLND) United States $0.222B 0.00
Celcuity (CELC) United States $0.218B 0.00
Syros Pharmaceuticals (SYRS) United States $0.215B 0.00
Affimed (AFMD) Germany $0.214B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.213B 0.00
TOCAGEN INC (TOCA) United States $0.210B 0.00
Synlogic (SYBX) United States $0.210B 0.00
Solid Biosciences (SLDB) United States $0.209B 0.00
Spero Therapeutics (SPRO) United States $0.209B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.204B 0.00
Urovant Sciences (UROV) United States $0.203B 0.00
Kala Pharmaceuticals (KALA) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.201B 0.00
Avid Bioservices (CDMO) United States $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.197B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.194B 0.00
Chiasma (CHMA) United States $0.191B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.191B 0.00
Celyad SA (CYAD) Belgium $0.190B 0.00
Liquidia Technologies (LQDA) United States $0.184B 0.00
Axovant Sciences (AXGT) United Kingdom $0.181B 0.00
Neothetics (EVFM) United States $0.181B 0.00
Compugen (CGEN) Israel $0.181B 0.00
BioTime (BTX) United States $0.177B 11.80
Cue Biopharma (CUE) United States $0.175B 0.00
Seres Therapeutics (MCRB) United States $0.174B 0.00
Gamida Cell (GMDA) Israel $0.173B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
Intec Pharma (NTEC) Israel $0.173B 0.00
Anavex Life Sciences (AVXL) United States $0.169B 0.00
Checkpoint Therapeutics (CKPT) United States $0.169B 0.00
BioXcel Therapeutics (BTAI) United States $0.168B 0.00
Strongbridge Biopharma (SBBP) United States $0.167B 9.66
Menlo Therapeutics (MNLO) United States $0.166B 0.00
CorMedix Inc (CRMD) United States $0.159B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.158B 0.00
Novavax (NVAX) United States $0.157B 0.00
Mustang Bio (MBIO) United States $0.153B 0.00
Eton Pharmaceuticals (ETON) United States $0.146B 0.00
XOMA (XOMA) United States $0.137B 0.00
Arbutus Biopharma (ABUS) Canada $0.135B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.135B 0.00
Provention Bio (PRVB) United States $0.132B 0.00
OSMOTICA PHARM (OSMT) United States $0.130B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.130B 0.00
VolitionRX (VNRX) Singapore $0.129B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.128B 0.00
Aptinyx (APTX) United States $0.125B 0.00
Trevena (TRVN) United States $0.124B 0.00
Allena Pharmaceuticals (ALNA) United States $0.119B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.116B 0.00
Organovo Holdings (ONVO) United States $0.116B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
Dyadic (DYAI) United States $0.115B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.115B 0.00
Verastem (VSTM) United States $0.114B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.113B 0.00
NantKwest (NK) United States $0.111B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.109B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Equillium (EQ) United States $0.105B 0.00
Catalyst Biosciences (CBIO) United States $0.103B 0.00
Selecta Biosciences (SELB) United States $0.099B 0.00
Unum Therapeutics (UMRX) United States $0.098B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.098B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
Cohbar (CWBR) United States $0.095B 0.00
Pluristem Therapeutics (PSTI) Israel $0.093B 0.00
Signal Genetics (MGEN) United States $0.092B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Aptose Biosciences (APTO) Canada $0.084B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Cocrystal Pharma (COCP) United States $0.078B 82.41
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
VTv Therapeutics (VTVT) United States $0.073B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 37.80
Prima BioMed (IMMP) Australia $0.067B 0.00
OVID THERAPEUTC (OVID) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.065B 0.00
Alcobra (ARCT) United States $0.063B 0.00
Eyenovia (EYEN) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Curis (CRIS) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Ophthotech (ISEE) United States $0.058B 0.00
Apricus Biosciences (SEEL) United States $0.056B 0.00
Hoth Therapeutics (HOTH) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
Zosano Pharma (ZSAN) United States $0.055B 0.00
Cidara Therapeutics (CDTX) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.055B 0.00
AZURRX BIOPHARM (AZRX) United States $0.050B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.048B 0.00
Clearside Biomedical (CLSD) United States $0.047B 0.00
Bellerophon Therapeutics (BLPH) United States $0.047B 0.00
Entera Bio (ENTX) Israel $0.046B 0.00
Evogene (EVGN) Israel $0.046B 0.00
Celldex Therapeutics (CLDX) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.043B 0.00
VIVUS (VVUS) United States $0.042B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.042B 0.00
Moleculin Biotech (MBRX) United States $0.042B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.040B 0.00
DiaMedica Therapeutics (DMAC) United States $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
OncoSec Medical (ONCS) United States $0.034B 0.00
Caladrius Biosciences (CLBS) United States $0.032B 0.00
Bionano Genomics (BNGO) United States $0.032B 0.00
Motif Bio Plc (MTFB) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Vical (VICL) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.026B 0.00
GTx (GTXI) United States $0.025B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
Adial Pharmaceuticals (ADIL) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Oragenics (OGEN) United States $0.022B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
ATyr Pharma (LIFE) United States $0.022B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.021B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Aileron Therapeutics (ALRN) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Histogenics (HSGX) United States $0.018B 0.00
IMMURON LTD (IMRN) Australia $0.018B 0.00
CytRx (CYTR) United States $0.018B 0.00
Advaxis (ADXS) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Edge Therapeutics (PDSB) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.86
Vital Therapies (IMUX) United States $0.011B 0.00
ARCA Biopharma (ABIO) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
BioPharmX (BPMX) United States $0.011B 0.00
Oncobiologics (OTLK) United States $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
AmpliPhi Biosciences (ARMP) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Alliqua BioMedical (ADYX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Cellect Biotechnology (APOP) Israel $0.004B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00